SCHEMBL6575692

SCHEMBL6575692

CCOC(=O)c1ccc(C#Cc2ccc3c(c2)N(c2ccc(C)cc2)C(=O)CC3(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.53
RARB P10826 7/20 0.50
RARG P13631 6/20 0.50
RARA P10276 6/20 0.50
ALDH1A1 P00352 5/20 0.44
HTT P42858 4/20 0.44
HSP90AA1 P07900 1/20 0.44
HPGD P15428 1/20 0.44
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
GAA P10253 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
PRKCG P05129 1/20 0.41
PRKCB P05771 1/20 0.41
PRKCA P17252 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCD Q05655 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6577982 0.87 RARB (0.66) RARBRARGRARACYP3A4
SCHEMBL8634937 0.82 RARB (0.74) MAPK1RARBRARGRARAKMT2A
SCHEMBL6578640 0.82 RARB (0.49) MAPK1RARBRARGRARAALDH1A1
SCHEMBL8616526 0.77 RARB (0.42) RARBRARGRARACACNA1BAPBA1
SCHEMBL6576642 0.77 POLB (0.41) MAPK1RARBRARGRARAALDH1A1
SCHEMBL8634168 0.77 RARB (0.74) MAPK1RARBRARGRARAKMT2A
SCHEMBL8605778 0.76 RARB (0.61) MAPK1RARBRARGRARAKMT2A
SCHEMBL8866305 0.74 RARB (0.71) MAPK1RARBRARGRARAALDH1A1
SCHEMBL8614817 0.74 RARB (0.52) RARBRARGRARAALDH1A1GAA
SCHEMBL8606834 0.74 RARB (0.51) MAPK1RARBRARGRARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed